Multipolar Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Multipolar Tbk. trades at Rp95 (market cap 1.55T, 46.53M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume). The key difference: Multipolar Tbk. is far larger — about 3.3× Prodia Diagnostic Line Tbk's market cap, and Multipolar Tbk. is more actively traded (46.53M versus 28.43M). Which is the better fit depends on your goals.
| MLPL | PRDL | |
|---|---|---|
Market Cap | 1.55T | 470.58B |
Volume | 46.53M | 28.43M |
Lot | 465.25K | 284.34K |
Turnover | 4.51B | 7.8B |
Average Price | 96.98 | 274.19 |
Value | 4.51B | 7.8B |
Indicative Equilibrium Price | 95 | 270 |
Indicative Equilibrium Volume | 16.68K | 2.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Multipolar Tbk (the Company) was established in the Republic of Indonesia on December 4, 1975 based on Notarial Deed No. 7 of Adlan Yulizar, S.H., which has beed amended several times, the latest by Notarial Deed No. 119 of Misahardi Wilamarta, S.H., dated March 25, 1982.
Read more on MLPL →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →